Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Event Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation Events
Foundation Events
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts
CABP Eligible
CABP Eligible

  • Saturday, Oct 25th
    8:15 AM - 9:15 AM  PT
    AM25-ST-03-L - Quality Agreements in Cell Therapy: Building Successful Partnerships
    Room: SDCC 30CDE
    Program Chair: Wanxing Cui, MD, PhD, CABP(H) – MedStar Georgetown University Hospital
    Speaker: Ronit Slotky, PhD, MSc, CABP – Hackensack University Medical Center
    Speaker: Sarah Clark, MBA (she/her/hers) – Michigan Medicine at the University of Michigan
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Saturday, Oct 25th
    10:45 AM - 12:15 PM  PT
    AM25-ST-14-L - Allogeneic Transplant, Gene Therapy, or the Evolving Drug Landscape in Sickle Cell Disease: Helping Patients Choose Between Options
    Room: SDCC 30CDE
    Program Chair: Patricia Shi, MD (she/her/hers) – New York Blood Center
    Speaker: Swee Lay Thein, MD, DSc., FMedSci – Sickle Cell Branch, NHLBI, NIH
    Speaker: Adetola Kassim, MD, MS – Vanderbilt University
    Speaker: Julie Kanter, MD (she/her/hers) – The University of Alabama at Birmingham
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Saturday, Oct 25th
    10:45 AM - 12:15 PM  PT
    AM25-ST-15-L - Solve It! Scenarios in Cellular Therapy
    Room: SDCC 31
    Speaker: Ronit Slotky, PhD, MSc, CABP – Hackensack University Medical Center
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Saturday, Oct 25th
    1:45 PM - 2:45 PM  PT
    AM25-ST-18-L - Ensuring Safe and Effective Distribution of Advanced Therapies: Unique Perspectives from Pharmacy and Cell Therapy Labs
    Room: SDCC 33
    Program Chair: Jeff Wren, MBA, CABP – AABB
    Speaker: Kim McConnell, PharmD, BCPS, CCRP – UCSD Medical Center
    Speaker: Kimberly Villar, MLS(ASCP), CLS (she/her/hers) – UC San Diego Health Stem Cell Processing Laboratory
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    8:15 AM - 9:15 AM  PT
    AM25-SN-07-L - Expanding CGT Access: The Role of Blood Centers in Last-Mile Delivery
    Room: SDCC 20BC
    Program Chair: Dominic Clarke – Cryoport
    Speaker: Becky M. Cap, MBA (she/her/hers) – Vitalant
    Speaker: Theresa Pina – Gulf Coast Blood
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    10:00 AM - 11:30 AM  PT
    PL5-SN-08 - Lyophilized Platelet Extracellular Vesicles Mitigate Intracranial Hemorrhage in a Murine Model of Traumatic Brain Injury by Delivering Hemostatic Proteins and mRNA Cargo
    Room: SDCC 20BC
    Presenting Author: Shibani Pati, MD PhD (she/her/hers) – University of California San Francisco
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Sunday, Oct 26th
    10:00 AM - 11:30 AM  PT
    PL6-SN-08 - Spray-dried Plasma: A Multi-center, Prospective, Randomized, Dose-escalation Cohort Safety Clinical Trial
    Room: SDCC 20BC
    Presenting Author: Mark Popovsky, MD (he/him/his) – Velico Medical
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Sunday, Oct 26th
    12:15 PM - 1:00 PM  PT
    P-BT-1 - Qualification of a Residual Peracetic Acid Assay for Amnion Patches Undergoing Supercritical CO2 Sterilization
    Room: SDCC Exhibit Hall F-H, AABB Learning Theater
    Presenting Author: Ileana Pedraza (she/her/hers) – BioBridge Global
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Sunday, Oct 26th
    12:15 PM - 1:00 PM  PT
    P-BT-2 - Two Distinct CD45 Positive Stem Cell Populations Within a Single Stem Cell Product – a Clinical Practice Conundrum
    Room: SDCC Exhibit Hall F-H, AABB Learning Theater
    Presenting Author: Aswath P. Padmanabhan Chandrasekar, MBBS – Mayo Clinic
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Sunday, Oct 26th
    12:15 PM - 1:00 PM  PT
    P-BT-3 - Umbilical Cord Blood Derived Macrophages (DUOC-01) Suppress Neuroinflammation by Limiting the Activation of CNS Barrier Endothelial Cells
    Room: SDCC Exhibit Hall F-H, AABB Learning Theater
    Presenting Author: Anthony J. Filiano, n/a – Duke University
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Sunday, Oct 26th
    2:30 PM - 3:30 PM  PT
    AM25-SN-13-L - Update on the Use of Cryopreserved Platelets in Acute Surgical Settings
    Room: SDCC 20D
    Speaker: Jose Cancelas (he/him/his) – Dana-Farber Cancer Institute
    Speaker: Glenn Whitman, MD (he/him/his) – Johns Hopkins School of Medicine
    Program Chair: Claudia Cohn, MD, PhD (she/her/hers) – University of Minnesota
    Speaker: Claudia Cohn, MD, PhD (she/her/hers) – University of Minnesota
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    2:30 PM - 3:30 PM  PT
    AM25-SN-18-L - Ensuring Ethical and Regulatory Compliance in Donor Collections for Advanced Therapies
    Room: SDCC 28BCDE
    Speaker: Christina Lueck, MT, ASCP – Blood Centers of America
    Program Chair: Vivienne Marshall, Ph.D (she/her/hers) – BBG Advanced Therapies
    Speaker: Evan Delay, RN, MSN (she/her/hers) – Bloodworks Northewest
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    3:45 PM - 4:45 PM  PT
    AM25-SN-21-L - Novel Tools and Platform Designs in Biotherapies
    Room: SDCC 20A
    Program Chair: Don Siegel, MD, PhD (he/him/his) – University of Pennsylvania
    Speaker: Panagiotis Mistriotis, PhD (he/him/his) – Auburn University
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    3:45 PM - 4:45 PM  PT
    AM25-SN-23-L - FcRN Inhibitors – a New Era for Transfusion Medicine?
    Room: SDCC 20D
    Speaker: Muharrem Yunce, MD (he/him/his) – Stanford Healthcare
    Speaker: Minh-Ha Tran, DO – UNIVERSITY OF CALIFORNIA, IRVINE
    Program Chair: Jeremy W. Jacobs, MD, MHS – Department of Pathology, Microbiology & Immunology, Vanderbilt University, Nashville, TN, USA
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Sunday, Oct 26th
    5:00 PM - 6:00 PM  PT
    AM25-SN-27-L - Revolutionizing Donor Selection: Integrating AI, Omics Data, and Large-Scale Cohorts for Improved Cell Therapy Outcomes
    Room: SDCC 30CDE
    Program Chair: Jeff Wren, MBA, CABP – AABB
    Speaker: Kat Kozyrytska, MS – Cell Therapy Manufacturability Program
    Speaker: Robert Tressler, MS, PhD – Excellos
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Monday, Oct 27th
    10:00 AM - 10:45 AM  PT
    AM25-MN-18-L - Oral Abstract Session - Advances in Cord Blood Therapy
    Room: SDCC 32
    Program Chair: Colleen Delaney, MD, MSc (she/her/hers) – Seattle Children’s Therapeutics (SCTx); Clinical Cell Processing Laboratory (CCPL); Seattle Children’s Research Institute (SCRI); University of WA, Dep’t of Pediatrics; Fred Hutch Cancer Center
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / .45 CE (Non-Physician Credit)
  • Monday, Oct 27th
    10:00 AM - 10:45 AM  PT
    #OA3-AM25-MN-18 - Analysis of Impact to HLA Coverage and Usability of Cord Blood Units Banked Between 2017 and 2024
    Room: SDCC 32
    Presenting Author: Christina Melief, PhD – National Cord Blood Network
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Monday, Oct 27th
    10:00 AM - 10:45 AM  PT
    #OA1-AM25-MN-18 - Ex Vivo and In Vivo Potency of CD34+ Hematopoietic Stem and Progenitor Cells Isolated from Cord Blood Using a Novel Technology
    Room: SDCC 32
    Presenting Author: Jonathan Messer, PhD (he/him/his) – 42Bio
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Monday, Oct 27th
    10:00 AM - 10:45 AM  PT
    #OA2-AM25-MN-18 - Umbilical Cord Blood Transplantation (UCBT) a Very Good Curative Option for Pediatric Patients with Congenital Disorders Even in the Setting of Underrepresented Minorities
    Room: SDCC 32
    Presenting Author: Caridad Martinez, MD – Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Monday, Oct 27th
    10:00 AM - 11:30 AM  PT
    AM25-MN-07-L - Cell Therapy Lab Jeopardy!
    Room: SDCC 31
    Speaker: Huy P. Pham, MD, MPH – NMDP
    Speaker: Diane Kadidlo, MT(ASCP) SBB – University of Minnesota
    Speaker: Cindy Roppe Stanaway, MT(ASCP) – University of MN
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Monday, Oct 27th
    2:30 PM - 3:30 PM  PT
    AM25-MN-14-L - Advancing Cord Blood Utilization: Building Pathways for Innovation and Clinical Adoption
    Room: SDCC 32
    Speaker: Christina Melief, PhD – National Cord Blood Network
    Speaker: Roger Horton – Anthony Nolan
    Speaker: Colleen Delaney, MD, MSc (she/her/hers) – Seattle Children’s Therapeutics (SCTx); Clinical Cell Processing Laboratory (CCPL); Seattle Children’s Research Institute (SCRI); University of WA, Dep’t of Pediatrics; Fred Hutch Cancer Center
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Monday, Oct 27th
    5:00 PM - 6:00 PM  PT
    AM25-MN-29-L - Unlocking the Power of Extracellular Vesicles: From Intercellular Communication to Therapeutic Innovation
    Room: SDCC 20BC
    Program Chair: Asawari Bapat, MBBS, DPB, PGDHHM, CABP(H), DABRM,FABRM (she/her/hers) – CEO & Founder, Questar Enterprise, LLC, Dubai, UAE; VP-Infohealth FZE, Dubai, UAE; Consultant- AABB Global Impact Consulting, MD, USA; Consultants- Oncology Services, London, UK; Consultant- Clinical Affairs, Regenerative Outcomes, LLC, Nashville, TN, USA; PO Box: 6824 UAE.
    Speaker: Asawari Bapat, MBBS, DPB, PGDHHM, CABP(H), DABRM,FABRM (she/her/hers) – CEO & Founder, Questar Enterprise, LLC, Dubai, UAE; VP-Infohealth FZE, Dubai, UAE; Consultant- AABB Global Impact Consulting, MD, USA; Consultants- Oncology Services, London, UK; Consultant- Clinical Affairs, Regenerative Outcomes, LLC, Nashville, TN, USA; PO Box: 6824 UAE.
    Speaker: Dimitrios Kouroupis, MSc, PhD  (he/him/his) – University of Miami, Miller School of Medicine 
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)
  • Tuesday, Oct 28th
    9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Oral Abstract Spotlight Session - Biotherapies & Cell Transplantation
    Room: SDCC 30AB
    Program Chair: Monika Paroder, MD, PhD – Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine
    Program Chair: Tobias Cohen, MD PhD – Weill Cornell Medicine
    Speaker: Yen-Michael Hsu, MD, PhD, MBA, CABP, QIA – Gift of Life Marrow Registry
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 0 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)
  • Tuesday, Oct 28th
    9:30 AM - 11:00 AM  PT
    #OA1-AM25-TU-15 - Duffy-Null Status and Delayed Neutrophil Engraftment in Autologous Hematopoietic Transplantation: A Call for Awareness
    Room: SDCC 30AB
    Presenting Author: Alexander J. Fenwick (he/him/his) – Cleveland Clinic Foundation, cleveland, ohio
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: N/A
  • Tuesday, Oct 28th
    9:30 AM - 11:00 AM  PT
    AM25-TU-16-L - Building a Translational Arm to Your Cellular Therapy Laboratory
    Room: SDCC 20D
    Speaker: Diane Kadidlo, MT(ASCP) SBB – University of Minnesota
    Speaker: Drew Witter, MS, RAC – Mayo Clinic
    Program Chair: Thane A. Kubik, MD, MS (he/him/his) – Alberta Precision Labs
    Biotherapies, Cellular Therapies, and Immunotherapies
     CE: 1.5 CME (AMA Physician Credit) / 1.5 CE (Non-Physician Credit)